Modulation of HSP70-dependent mechanisms of endogenous neuroprotection with selenium derivatives under conditions of ischemic-type acute cerebrovascular accident modeling
DOI:
https://doi.org/10.12775/PPS.2020.06.04.009Keywords
selenium derivatives, HSP70, dependent mechanisms, neuroprotection, acute cerebrovascular accidentAbstract
The influence of selenium derivatives selenoline, cysteine selenate, and methionine selenate on the main indicators of HSP70-dependent mechanisms of endogenous neuroprotection under conditions of acute cerebrovascular accident (CVA) modeling has been investigated, and pathogenetic substantiation of prospects for their further study as potential neuroprotectors has been given. The experiments have been performed on white Wistar rats by bilateral irreversible ligation of the common carotid artery. Cysteine selenite and methionine selenite at a dose of 30 μg/kg, and selenoline at a dose of 50 μg/kg were introduced intraperitoneally to the experimental animals once-daily for 4 days. Every day for 4 days, the severity of neurological reactions was assessed in points on a stroke-index scale, and the mortality rate in animals was recorded. In the process of biochemical studies of brain tissue, the state of mRNA expression, HSP70 level, hypoxia-induced factors (HIF) – HIF1α and HIF-3α were evaluated using the method of polymerase chain reaction (PCR) with real-time reverse transcription. While false-operated animals developed mild neurological disorders, the control group developed bilateral ptosis, circling movements, paresis and paralysis of the limbs. On the 4th day the mean score on Stroke-index P. McGraw neurological deficit assessment scale was 16.7 ± 0.52, and 40 % of animals survived. In the cytosol and mitochondria of brain tissues, a decrease in HSP70 was detected by 47% and 59%, respectively. The administration of selenite cysteine, selenite methionine and selenoline contributed to the normalization of this indicator, to a greater extent under the action of selenite cysteine. In the control group there was a decrease in HSP70 mRNA expression. After administration of all the studied compounds, a tendency to increase the expression of HSP70 mRNA was observed compared to the controls. Under conditions of cerebral circulation insufficiency ACCI, in brain tissue, a decrease in the synthesis of HIF-1α at the stage of translation with ATP deficiency was noted. The course administration of selenium-containing drugs to rats with ACCI induced an increase in HIF1α levels: cysteine selenite – by 11.2 times, selenite methionine – by 3.13 times, and selenoline – by 1.1 times (p ˃0.05). A significant difference in relation to the expression of HIF-3α was shown only after administration of cysteine selenite (by 4.3 times higher than the control). The study of antioxidant modulation of HSP70-dependent mechanisms of endogenous neuroprotection of the brain have demonstrated that administration of selenium-containing medications cysteine selenite, methionine selenite, and selenoline lead to a decrease in neurological signs and the mortality rate in animals with ACCI. The action of selenium-containing drugs is realized due to their positive influence on the glutathione system, the preservation of energy-producing function of organs and mitoprotective effect. The obtained results indicate the relevance of further study of selenium-containing drugs on other models of pathological processes accompanied by ischemia.References
Belenichev I. F., Bila Yu. V. Relationships between HSP70 concentrations, an active thiol-disulfide system and neurological disorders level in acute cerebral ischemia model. Bulletin of Problems in Biology and Medicine. 2017;1:86–91. URL : http://vpbm.com.ua/upload/2017-1/17.pdf
Belenichev I.F., Cherny V.I., Nagornaya E.A., Pavlov S.V., Cherny T.V. et al [Neuroprotection and Neuroplasticity]. Kyiv: Logos, 2015. 510 p. Russian
Belenichev I.F., Gorbacheva S.V., A.V. Demchenko, Bukhtiyarova N.V. The thiol-disulfide balance and the nitric oxide system in the brain tissue of rats’ subjected to experimental acute impraiment of cerebral blood flow: the therapeutic effects of nootropic drugs. Neurochemical Journal. 2014;1(8): 24-27. doi: http:// DOI: 10.1134/S181971241401005X
Belenichev I.F., Mazur I.A., Abramov A.V., Kucherenko L.I., Bukhtiayarova N.V. The endothelium-protective effect of 3-methyl-1,2,4-triazolyl-5-thioacetate (S)-2,6-diaminohexanic acid (lysinium): Effects on the expression of vascular endothelial growth factor (VEGF) and the characteristics of the endotheliocytes of the cerebral vessels of animals with cerebral ischemia. Neurochemical Journal. 2013;7. 296–302. doi: https://doi.org/10.1134/S181971241304003X
Belenichev I.F., Mazur, L.I. Kucherenko, Nagornaya E.A., Gornacheva S.V. et al. The Molecular and Ultrastructural Aspects of the Formation of Mitochondrial Dysfunction in the Modeling of Chronic Cerebral Ischemia: the Mitoprotective Effects of Angiolin. Neurochemical Journal. 2016;2(10).131–136. doi: http:// DOI: 10.1134/S1819712416010025
Belenichev I.F., Pavlov S.V., Bukhtiayarova N.V., Samura I.B., Egorov A.N., Semenov D.M. Expression of HSP70 in the Brain of Rats During Experimental Cerebral Ischemia Modeling and on the Background of Neuroprotection. Biological Markers and Guide Therapy 2017;1(4):105-111. doi:https://doi.org/10.12988/bmgt.2017.7911
Belenichev I., Ryzhenko V.P., Ryzhov A.A. Analysis of influence of Quantum Chemical Descriptors on NO-Scavenger Properties among Xantine Derivatives. Biological Markers and Guide Therapy. 2017. № 1. P.39–48. doi: http:// DOI: 10.12988/bmgt.2017.735.
Chekman I.S., Belenichev I.F., Nagornaya E.A., Gorchakova N.A., Bukhtiyarova N.V. et al. [Pre-clinical study of specific activity of potential endothelioprotective drugs. Methodological instructions]: http://www.m-hikari.com/bmgt/bmgt2018/bmgt1-2018/p/belenichevBMGT1-2018.pdfКyiv: TOV Vidavnitstvo Yuston, 2016. 82 p. Ukrainian
Klimenko L.L., Skalny A.V., Turna A.A., Kuznetsova A.V., Senko O.V. et al. The role of selenium in the multivariate etiopathogenesis of ischemic stroke. The Trace Eliments in Medicine. 2015;16(4):28-35. doi: http:// DOI: 10.19112/2413-6174-2015-16-4-28-35
Nefodov A.A., Belenichev I. F., Nefodova E.A., Bukhtiyarova N.V., Levich N.V., Dronov S.N. Neuroprotective effect of citicoline and glucocorticoid combination under conditions of experimental demyelinating model of central nervous system. Journal of Neurobehavioral Sciences.2018;3:131-136. doi: http:// DOI : 10.5455/JNBS.1525619232
Radons J. The human HSP70 family of chaperones: where do we stand? J. Cell Stress Chaperones. 2016;21:379–404 [PMC free article] [PubMed doi: http:// doi: 10.1007/s12192-016-0676-6
Ryzhenko V. P., Ryzhov O.A., Belenichev I.F., Levich S.V. Study of dependence of xanthine derivatives NO-scavenger properties from energy descriptors. Biological Markers and Guided Therapy. 2018;1:37–46. doi: https://doi.org/10.12988/bmgt.2018.857
Sharp F.R., Zhan X, Liu DZ. Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential. Transl Stroke Res 2013;4(6):685-92. doi: http:// doi: 10.1007/s12975-013-0271-4
Sun, Y., He, W., & Geng, L. Neuroprotective mechanism of HIF-1α overexpression in the early stage of acute cerebral infarction in rats. Experimental and Therapeutic Medicine.2016;12(1):391-395. doi: 10.3892/ etm.2016.3288.
Weekly C.M., Harris H.H. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev. 2013;42:.8870-94. doi: http:// DOI: 10.1039/c3cs60272a
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 616
Number of citations: 0